⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Carbonotrithioic Acid SCHEMBL27903774 | 0.72 | CA1 (1.00) | — | |
| Carbonotrithioic Acid SCHEMBL19959 | 0.72 | — | — | |
| Carbonotrithioic Acid SCHEMBL5146473 | 0.72 | — | — | |
| Carbonotrithioic Acid SCHEMBL28659704 | 0.67 | — | — | |
| Carbonotrithioic Acid SCHEMBL28904102 | 0.67 | — | — | |
| Carbonotrithioic Acid SCHEMBL10773341 | 0.67 | — | — | |
| Carbonotrithioic Acid SCHEMBL29205729 | 0.67 | — | — | |
| SCHEMBL1256635 | 0.67 | — | — | |
| Carbonotrithioic Acid SCHEMBL7959788 | 0.67 | — | — | |
| SCHEMBL5691 | 0.67 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 90 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-101102762-A | Compositions including iron | DRUGTECH CORP (US) | 2008-01-09 | — | — | CN | claimed |
| EP-1827418-A2 | COMPOSITIONS INCLUDING IRON | Drugtech Corporation (US) | 2007-09-05 | — | — | EP | claimed |
| EP-1827419-A2 | METHODS AND COMPOSITIONS FOR ENHANCING IRON ABSORPTION | Drugtech Corporation (US) | 2007-09-05 | — | — | EP | claimed |
| WO-2006068697-A2 | COMPOSITIONS INCLUDING IRON | DRUGTECH CORPORATION (US) | 2006-06-29 | — | — | WO | claimed |
| WO-2006068729-A2 | METHODS AND COMPOSITIONS FOR ENHANCING IRON ABSORPTION | DRUGTECH CORPORATION (US) | 2006-06-29 | — | — | WO | claimed |
| US-20060134227-A1 | Compositions including iron | DRUGTECH CORPORATION | 2006-06-22 | — | — | US | claimed |
| WO-2003086321-A2 | MODIFIED RELEASE MINERALS | DRUGTECH CORPORATION (US) | 2003-10-23 | — | — | WO | claimed |
| US-20030190355-A1 | Modified release minerals | DRUGTECH CORPORATION | 2003-10-09 | — | — | US | claimed |
| CN-116636620-B | Black egg white peptide composition and application thereof | 南昌大学 | 2025-02-14 | — | — | CN | disclosed |
| WO-2024263116-A1 | A STABLE CAPSULE COMPOSITION WITH GASTRO-RESISTANT PELLETS FOR THE TREATMENT OF IRON DEFICIENCY ANEMIA | ILKO ILAC SANAYI VE TICARET A.S. (TR) | 2024-12-26 | — | — | WO | disclosed |
| WO-2023119230-A1 | COAGULATION PATHWAY AND NICOTINAMIDE-ADENINE DINUCLEOTIDE PATHWAY MODULATING COMPOSITIONS AND METHODS OF THEIR USE | L'OREAL (FR) | 2023-06-29 | — | — | WO | disclosed |
| US-20220160830-A1 | COMPOSITIONS COMPRISING CHOLINE | JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT | 2022-05-26 | — | — | US | disclosed |
| US-11278591-B2 | Compositions comprising choline | BALCHEM CORPORATION (US) | 2022-03-22 | — | — | US | disclosed |
| US-10463629-B2 | Patches and methods for the transdermal delivery of a therapeutically effective amount of iron | FE3 MEDICAL, INC. (US) | 2019-11-05 | — | — | US | disclosed |
| WO-2006068697-A2 | COMPOSITIONS INCLUDING IRON | DRUGTECH CORPORATION (US) | 2006-06-29 | — | — | WO | disclosed |
| US-20060134227-A1 | Compositions including iron | DRUGTECH CORPORATION | 2006-06-22 | — | — | US | disclosed |
| WO-2005120524-A2 | NUTRITIONAL FORMULATIONS | DRUGTECH CORPORATION (US) | 2005-12-22 | — | — | WO | disclosed |
| US-20050037065-A1 | NUTRITIONAL FORMULATIONS | DRUGTECH CORPORATION (US) | 2005-02-17 | — | — | US | disclosed |
| WO-2003086321-A2 | MODIFIED RELEASE MINERALS | DRUGTECH CORPORATION (US) | 2003-10-23 | — | — | WO | disclosed |
| US-20030190355-A1 | Modified release minerals | DRUGTECH CORPORATION | 2003-10-09 | — | — | US | disclosed |